Relmada Therapeutics, Inc.: shareholders and insiders

RLMDNASDAQHealthcare · Pharmaceutical Preparations

Price

$2.62

November 20, 2026Market cap $280M

What Ploutos Investor adds for Relmada Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 13 fiscal years, from FY2012
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 37% since Nov 12, 2026, when the 10-Q these figures come from was filed ($4.16 then, $2.62 on Nov 20, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Sep 11, 2026, from their own Form 4 filings.

2 Form 4s

Bought on the market

$1.8M

2 people

Sold on the market

–

nobody

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $1.7M by 2 people·no sales

  • 2025: bought $161.4K by 2 people, no sales
  • 2026: bought $1.7M by 2 people, no sales
  • Sep 10, 2026Maged ShenoudaChief Financial Officer
    Kind
  • Sep 10, 2026Sergio TraversaChief Executive Officer
    Kind
  • Sep 9, 2026Maged ShenoudaChief Financial Officer
    Kind
  • Sep 9, 2026Sergio TraversaChief Executive Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Sep 11, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by RLMD's officers and directors from 2015 up to November 21, 2025, 11 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

6 Holders over 5%Aug 14, 2026 Latest filing
  • Janus Henderson Group
    Share of class10.1%
  • BlackRock, Inc.
    Share of class7.00%
  • Squadron Master Fund LPwith 3 more persons
    Share of class7.00%
  • Venrock Healthcare Capital Partners III, L.P.with 6 more persons
    Share of class6.20%
  • Spruce Street Capital LPwith 2 more persons
    Share of class5.57%
  • Commodore Capital LPwith 3 more persons
    Share of class5.10%
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Millennium Management LLC4.40%Jun 22, 202613G
  • Adage Capital Management, L.P.4.54%May 13, 202613G/A
  • Ikarian Capital, LLC4.80%Nov 14, 202513G

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Millennium Mgmt (Englander)
    In the quarter+42%
  • Citadel Advisors (Griffin)
    In the quarter-58%
  • D.E. Shaw
    In the quarter+282%
  • Renaissance Technologies
    In the quarter+771%
  • AQR Capital
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 11.4% of its shares outstanding were held short, -9.3% since the report before.

Shares held short
12.18M
11.4%
Since the report before13.42M on Sep 30, 2026
-9.3%
8.5
1.43M
More days to cover thanof 4,578 US-listed companies with enough volume
86%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 794.7K
  • Nov 15, 2023: Shares held short 875.2K
  • Nov 30, 2023: Shares held short 865.8K
  • Dec 15, 2023: Shares held short 638.8K
  • Dec 29, 2023: Shares held short 810.6K
  • Jan 12, 2024: Shares held short 1.56M
  • Jan 31, 2024: Shares held short 1.61M
  • Feb 15, 2024: Shares held short 1.73M
  • Feb 29, 2024: Shares held short 1.75M
  • Mar 15, 2024: Shares held short 1.75M
  • Mar 28, 2024: Shares held short 1.69M
  • Apr 15, 2024: Shares held short 1.71M
  • Apr 30, 2024: Shares held short 1.64M
  • May 15, 2024: Shares held short 1.57M
  • May 31, 2024: Shares held short 1.54M
  • Jun 14, 2024: Shares held short 1.55M
  • Jun 28, 2024: Shares held short 1.01M
  • Jul 15, 2024: Shares held short 1.36M
  • Jul 31, 2024: Shares held short 1.33M
  • Aug 15, 2024: Shares held short 1.29M
  • Aug 30, 2024: Shares held short 1.21M
  • Sep 13, 2024: Shares held short 1.18M
  • Sep 30, 2024: Shares held short 1.25M
  • Oct 15, 2024: Shares held short 1.26M
  • Oct 31, 2024: Shares held short 1.19M
  • Nov 15, 2024: Shares held short 1.15M
  • Nov 29, 2024: Shares held short 1.06M
  • Dec 13, 2024: Shares held short 1.78M
  • Dec 31, 2024: Shares held short 1.65M
  • Jan 15, 2025: Shares held short 1.25M
  • Jan 31, 2025: Shares held short 838.0K
  • Feb 14, 2025: Shares held short 1.75M
  • Feb 28, 2025: Shares held short 1.26M
  • Mar 14, 2025: Shares held short 1.49M
  • Mar 31, 2025: Shares held short 1.62M
  • Apr 15, 2025: Shares held short 1.41M
  • Apr 30, 2025: Shares held short 2.03M
  • May 15, 2025: Shares held short 1.22M
  • May 30, 2025: Shares held short 1.13M
  • Jun 13, 2025: Shares held short 695.5K
  • Jun 30, 2025: Shares held short 595.0K
  • Jul 15, 2025: Shares held short 423.9K
  • Jul 31, 2025: Shares held short 401.3K
  • Aug 15, 2025: Shares held short 478.4K
  • Aug 29, 2025: Shares held short 557.3K
  • Sep 15, 2025: Shares held short 711.3K
  • Sep 30, 2025: Shares held short 835.7K
  • Oct 15, 2025: Shares held short 562.4K
  • Oct 31, 2025: Shares held short 514.1K
  • Nov 14, 2025: Shares held short 946.5K
  • Nov 28, 2025: Shares held short 772.9K
  • Dec 15, 2025: Shares held short 980.7K
  • Dec 31, 2025: Shares held short 1.39M
  • Jan 15, 2026: Shares held short 1.43M
  • Jan 30, 2026: Shares held short 1.26M
  • Feb 13, 2026: Shares held short 1.11M
  • Feb 27, 2026: Shares held short 836.3K
  • Mar 13, 2026: Shares held short 3.73M
  • Mar 31, 2026: Shares held short 6.04M
  • Apr 15, 2026: Shares held short 6.19M
  • Apr 30, 2026: Shares held short 5.35M
  • May 15, 2026: Shares held short 5.49M
  • May 29, 2026: Shares held short 5.84M
  • Jun 15, 2026: Shares held short 6.06M
  • Jun 30, 2026: Shares held short 10.65M
  • Jul 15, 2026: Shares held short 12.99M
  • Jul 31, 2026: Shares held short 13.56M
  • Aug 14, 2026: Shares held short 12.89M
  • Aug 31, 2026: Shares held short 13.60M
  • Sep 15, 2026: Shares held short 14.46M
  • Sep 30, 2026: Shares held short 13.42M
  • Oct 15, 2026: Shares held short 12.18M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading54.0% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 54.0% of the shares in the reported trades were short sales, against 43.6% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
54.0%
The 14 beforeOct 14, 2026 – Nov 2, 2026
43.6%
Change
+10.4 pts
Short sales a dayon average, of 607.0K shares
327.5K
More than atof 3,666 US-listed companies, same days
63%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 50.3%
  • Oct 15, 2026: Short sales 67.9%
  • Oct 16, 2026: Short sales 81.8%
  • Oct 19, 2026: Short sales 64.7%
  • Oct 20, 2026: Short sales 61.6%
  • Oct 21, 2026: Short sales 53.8%
  • Oct 22, 2026: Short sales 15.7%
  • Oct 23, 2026: Short sales 76.6%
  • Oct 26, 2026: Short sales 60.5%
  • Oct 27, 2026: Short sales 29.3%
  • Oct 28, 2026: Short sales 43.9%
  • Oct 29, 2026: Short sales 29.5%
  • Oct 30, 2026: Short sales 63%
  • Nov 2, 2026: Short sales 77.8%
  • Nov 3, 2026: Short sales 53.9%
  • Nov 4, 2026: Short sales 50.6%
  • Nov 5, 2026: Short sales 51.5%
  • Nov 6, 2026: Short sales 55.2%
  • Nov 9, 2026: Short sales 58%
  • Nov 10, 2026: Short sales 78.3%
  • Nov 11, 2026: Short sales 62.8%
  • Nov 12, 2026: Short sales 61.9%
  • Nov 13, 2026: Short sales 63.7%
  • Nov 16, 2026: Short sales 34.9%
  • Nov 17, 2026: Short sales 61.1%
  • Nov 18, 2026: Short sales 50.5%
  • Nov 19, 2026: Short sales 60.7%
  • Nov 20, 2026: Short sales 49.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

3.42M Insiders' shares3.26% Of the company
  • Sergio TraversaChief Executive Officer
    Directly1.50M
  • Maged ShenoudaChief Financial Officer
    Directly1.00M
  • Paul Edward KellyChief Operating Officer
    Directly502.3K
  • Chuck EnceCAO and COO
    Directly403.9K
  • Charles J CasamentoDirector
    Directly13.0K

A lower bound: it counts only the 5 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

10 ETFs holding it0.14% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.14%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.04%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.02%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.01%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.00%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%
  • ONEQFidelity Nasdaq Composite Index ETF
    Weight in the fund0.00%
  • IWViShares Russell 3000 ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

10 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

126 Managers, Q2 2026$694M Value of their positions
  • Q3 2025: Managers 44
  • Q4 2025: Managers 78
  • Q1 2026: Managers 104
  • Q2 2026: Managers 126

Institutional investors by quarter

The fund managers holding RLMD, quarter by quarter, from Q2 2016 to Q2 2025, 24 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 126 managers held 100M shares, worth $694M. During the quarter 46 opened a position, 25 closed one, 34 added and 22 trimmed.

The largest holders, Q2 2026

  • Jupiter Topco
    In the quarter
  • BlackRock
    In the quarter+476%
  • Squadron Capital Management
    In the quarter-13%
  • Venrock Adviser
    In the quarter+41%
  • Spruce Street Capital
    In the quarter+2.1%
  • Adage Capital Partners Gp
    In the quarter
  • Vanguard Capital Management
    In the quarter+45%
  • Jones Hill Capital
    In the quarter×10.7
  • Orbimed Advisors
    In the quarter-23%
  • State Street
    In the quarter+605%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Relmada Therapeutics's filings show?

Who buys and sells is one part of Relmada Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about RLMD's shareholders

Didn't find what you were looking for?

Ask us
Have RLMD's insiders bought or sold?

From Sep 11, 2026 to Sep 11, 2026 Relmada Therapeutics's insiders bought $1.7M and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold RLMD?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $13M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.